Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Relmada Therapeutics Inc (NASDAQ: RLMD) closed the day trading at $4.32 up 5.88% from the previous closing price of $4.08. In other words, the price has increased by $5.88 from its previous closing price. On the day, 0.6 million shares were traded. RLMD stock price reached its highest trading level at $4.33 during the session, while it also had its lowest trading level at $4.05.
Ratios:
For a better understanding of RLMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Jefferies on December 22, 2025, initiated with a Buy rating and assigned the stock a target price of $69.
On November 19, 2025, Mizuho Upgraded its rating to Outperform which previously was Neutral but kept the price unchanged to $10.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, whereas the target price for the stock was revised from $23 to $1.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 15 ’25 when TRAVERSA SERGIO bought 27,500 shares for $4.12 per share. The transaction valued at 113,300 led to the insider holds 1,300,000 shares of the business.
Shenouda Maged bought 11,665 shares of RLMD for $48,060 on Dec 15 ’25. The Chief Financial Officer now owns 800,000 shares after completing the transaction at $4.12 per share. On Nov 05 ’25, another insider, Shenouda Maged, who serves as the Chief Financial Officer of the company, bought 500,000 shares for $2.20 each. As a result, the insider paid 1,100,000 and bolstered with 788,335 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 316801280 and an Enterprise Value of 302914720.
Stock Price History:
The Beta on a monthly basis for RLMD is 0.77, which has changed by 8.902913 over the last 52 weeks, in comparison to a change of 0.19182634 over the same period for the S&P500. Over the past 52 weeks, RLMD has reached a high of $5.12, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 11.99%, while the 200-Day Moving Average is calculated to be 164.66%.
Shares Statistics:
Over the past 3-months, RLMD traded about 1.13M shares per day on average, while over the past 10 days, RLMD traded about 557900 shares per day. A total of 73.33M shares are outstanding, with a floating share count of 63.14M. Insiders hold about 13.90% of the company’s shares, while institutions hold 14.57% stake in the company. Shares short for RLMD as of 1765756800 were 980736 with a Short Ratio of 0.87, compared to 1763078400 on 946511. Therefore, it implies a Short% of Shares Outstanding of 980736 and a Short% of Float of 1.35.
